Cardlytics Inc
CDLX
Get informed when a big investor buys or sells
+ Follow
Current Fair Value
320.9% upsideUndervalued by 320.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $30.20 Million |
|---|---|
| Enterprise Value | $207.29 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-19.5 |
| Beta | 0.58 |
| Outstanding Shares | 5,489,600 |
Return
| Return on Equity | 2365.38% |
|---|---|
| Return on Assets | -35.88% |
| Return on Invested Capital | -14.07% |
Valuation & Multiples
| P/E Ratio | -0.29 |
|---|---|
| PEG | 0.44 |
| Price to Sales | 0.13 |
| Price to Book Ratio | -4.97 |
| Enterprise Value to Revenue | 1.01 |
| Enterprise Value to EBIT | -7.2 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 1.03 |
| Debt to Equity | -53.15 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Next Earnings Call
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2303▼ 25.84% |
|---|---|
| Total Calls | 813,300▼ 5.57% |
| Total Puts | 187,300▼ 55.50% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 32.46%▼ 8.33% |
|---|---|
| Total Invested | $18.10M▼ 27.86% |
| Investors Holding | 66▼ 9.00% |
ESG Score
No data
About Cardlytics Inc
CEO: Lynne Laube Relevant Senate Committees
This committee regulates the entire financial system, including banks, which are core partners for Cardlytics. Changes in bank capital requirements, consumer finance protection, or data sharing regulations could directly impact Cardlytics' business model and its ability to operate within financial ecosystems.
This committee's vast jurisdiction over interstate commerce, the FTC, and privacy laws is highly relevant. Cardlytics deals extensively with consumer data for advertising, making it susceptible to regulations on privacy, data security, and advertising practices overseen by this committee.